Navigation Links
Gene abnormality found to predict childhood leukemia relapse
Date:1/7/2009

Scientists have identified mutations in a gene that predict a high likelihood of relapse in children with acute lymphoblastic leukemia (ALL). Although the researchers caution that further research is needed to determine how changes in the gene, called IKZF1 or IKAROS, lead to leukemia relapse, the findings are likely to provide the basis for future diagnostic tests to assess the risk of treatment failure. By using a molecular test to identify this genetic marker in ALL patients, physicians should be better able to assign patients to appropriate therapies.

The findings of the Children's Oncology Group (COG) study, led by scientists from St. Jude Children's Research Hospital, Memphis, Tenn., the University of New Mexico Cancer Research and Treatment Center, Albuquerque, N.M., and the National Cancer Institute (NCI), part of the National Institutes of Health, appear online Jan.7, 2009, in the New England Journal of Medicine, and in print on Jan. 29, 2009.

ALL, a cancer of the white blood cells, is the most common childhood cancer, in that it affects about one in 29,000 children annually. Using currently available therapies, cure rates for ALL are now upwards of 80 percent. However, those therapies carry with them substantial side effects, and even with treatment, only 30 percent of children who experience a relapse of ALL will survive five years. Determining the risk of relapse faced by an individual patient would help physicians tailor treatment intensity appropriately, but until now there has been no good marker for predicting outcome.

"Great progress has been made in recent years in improving the cure rate of childhood ALL," said Stephen Hunger, M.D., chairman of the COG ALL committee and the lead COG investigator on this study. "The findings of this study help us further subdivide those patients who are unlikely to be cured, and identify patients in whom different therapies should be tested."

In the study, resear
'/>"/>

Contact: NCI Office of Media Relations
ncipressofficers@mail.nih.gov
301-496-6641
NIH/National Cancer Institute
Source:Eurekalert

Page: 1 2 3 4

Related medicine news :

1. Urologists report success using robot-assisted surgery for urinary abnormality
2. Study links primary insomnia to a neurochemical abnormality in young and middle-aged adults
3. One Species Genome Found Within Another
4. National Patient Safety Foundation Partners with Vocera Communications
5. R. P. Simmons Family Foundation Pledges $2 Million for New Childrens Hospital of Pittsburgh of UPMC Campus
6. Patient Advocate Foundation Launches Program to Help Uninsured Virginians with Chronic, Debilitating and Life-Threatening Illness Access Quality Healthcare
7. AIDS Healthcare Foundation Applauds City Commissioners Support of Diversity, Urges Call for Mayors Resignation
8. National Osteoporosis Foundation Teams Up With Ladies Home Journal Magazine to Launch a 10-city Mall Walk Tour
9. Judge Rules That Florida Disease Management Program Serving 8,000 HIV/AIDS Patients Should Be Re-bid, Says AIDS Healthcare Foundation
10. The Tug McGraw Foundation Announces 2007 Fundraising Gala
11. The Arthur M. Blank Family Foundation Pushes for Pre-K Expansion in Georgia

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/9/2009)...tudy finds , , MONDAY, Nov. 9 (HealthDay...atrial enlargement, which increases the risk of at...hows. , Atrial fibrillation is the most common ...eartbeat). , Researchers analyzed data on 1,21...e followed for 10 years. The study authors conclud...
(Date:11/9/2009)...everybody,s buzz word today and for Recruiters and... Recruiters and Staffers create their own private ... and close positions. The site also enables indivi...k with recruiters. , (PRW...everyone to network more than ever and by the laun...
(Date:11/9/2009)... mood despite similar weight loss , , MO...low-carbohydrate diet such as the popular Atkins p...p people lose pounds over the course of a year. ,...esult in long-term improvement in mood, according ...ernal Medicine . , People on both diets consume...
(Date:11/9/2009)...e-FirstCall/ - Hard To Treat Diseases (HTDS.PK) w..., a US$41 billion international healthcare company...partner, Zhejiang Tianyuan Bio-Pharmaceutical Co.,... will begin a five-year, $1 billion China initiati...crease its investment in its China R&D facilit...
(Date:11/9/2009)...Offered in April 2010, Provides First Responders w...Cambridge, MA (Vocus) November 9, 2009 -- When Ste...irst inspected a suspected mass grave at Dasht-e-... team of experts to help interpret the scene. He k...irst step in securing evidence of a human rights v...
Breaking Medicine News(10 mins):Health News:Launching StaffingClub.com, a New Online Networking Platform for Recruiting and Staffing Professionals 2Health News:To Feel Better, Low-Fat Diet May Be Best 2Health News:To Feel Better, Low-Fat Diet May Be Best 3Health News:Novartis to Acquire Majority Stake in Hard to Treat Diseases' (HTDS.PK) China Subsidiary H1N1 Vaccine Partner for US$125 Million 2Health News:Novartis to Acquire Majority Stake in Hard to Treat Diseases' (HTDS.PK) China Subsidiary H1N1 Vaccine Partner for US$125 Million 3Health News:Novartis to Acquire Majority Stake in Hard to Treat Diseases' (HTDS.PK) China Subsidiary H1N1 Vaccine Partner for US$125 Million 4Health News:Physicians for Human Rights Offers Training in Crime Scene Documentation 2Health News:Physicians for Human Rights Offers Training in Crime Scene Documentation 3Health News:Physicians for Human Rights Offers Training in Crime Scene Documentation 4
...Austin and,Amadeus North America, Inc. will receiv...nd for a corporation in recognition of their contr...s will be presented on Friday,February 15 at the S...rn Cruise Line, one of the most influential and in...
...s was able to identify the location and defect in ...genetic material (DNA) from members of a large Swi...somal dominant juvenile cataract. The correspondin... also lead to the condition of renal glucosuria, a...
...ience University Cancer Institute researcher has f... to predict if a mans prostate cancer is going to ...make this discovery, researchers examined prostate...cing of the gene CDH13 had a five-fold increased r...
...ic,Corporation (NYSE: BSX ) today announced that ...and Venous Access businesses to Avista Capital,Par...he definitive,agreement announced on December 13, ...ion., "The sale of the Fluid Management and Venou...
...ontinuing its commitment to honor invention and in...recognized the next group of world-class inventors...influential class includes inventors such as Nick ...l that converted solar energy into electrical powe...
... Minnesotans, MINNEAPOLIS, Feb. 14 Many smokers ... birthday or holiday as a "quit date.",Valentine,s...perfect day to,quit smoking for that special someo...uitting, such as not smelling like smoke,are obvio...
Other Medicine News:Health News:Executive Alison Austin and Amadeus North America Receive Deborah Natansohn Awards for Support of Heart Disease Awareness in Women 2Health News:New cataract gene discovered 2Health News:OHSU cancer institute researcher discovers new predictor of prostate cancer recurrence 2Health News:Boston Scientific Completes Sale of Fluid Management and Venous Access Businesses to Avista Capital Partners 2Health News:Boston Scientific Completes Sale of Fluid Management and Venous Access Businesses to Avista Capital Partners 3Health News:Boston Scientific Completes Sale of Fluid Management and Venous Access Businesses to Avista Capital Partners 4Health News:National Inventors Hall of Fame announces 2008 inductees 2Health News:National Inventors Hall of Fame announces 2008 inductees 3Health News:National Inventors Hall of Fame announces 2008 inductees 4Health News:QUITPLAN(R) Services Can Help Make Valentine's Day Smoke-Free 2Health News:QUITPLAN(R) Services Can Help Make Valentine's Day Smoke-Free 3
(Date:11/9/2009)... AMD LASERS just announced that in...e, has accepted the position of Medical Director. ...r overseeing research and development of new soft ...iance for continuing education credits, authoring ...ations, and lecturing and seminar engagements. ,...
(Date:11/9/2009).... 9 Access MediQuip, LLC, the nati...antable medical device management solutions to the...elocating its corporate headquarters to Lake Mary,...ued rapid growth, includes a major expansion of th...pen in January 2010 and relocation and expansion o...
(Date:11/9/2009)...v. 9 Thomson Reuters today annou...Focus, a leading clinical surveillance solution th...in real-time and respond immediately to improve cl... ,, This upgrade is available to current CareFo...ocus 2.0 contains several powerful enhancements th...
Breaking Medicine Technology:AMD LASERS Names Dr. James Jesse as Medical Director 2Access MediQuip Moves Company Headquarters to Lake Mary, Florida 2Thomson Reuters Clinical Surveillance Solution Offers Powerful New Functionality to Improve Clinical Quality and Reduce Costs 2Thomson Reuters Clinical Surveillance Solution Offers Powerful New Functionality to Improve Clinical Quality and Reduce Costs 3HealthCare Partners IPA Dr Richard Merkin CEO Recognize Seniors Taking Their Healthcare Concerns Directly to Lawmakers in Washington DC 5314 1HealthCare Partners IPA Dr Richard Merkin CEO Recognize Seniors Taking Their Healthcare Concerns Directly to Lawmakers in Washington DC 5314 2HealthCare Partners IPA Dr Richard Merkin CEO Recognize Seniors Taking Their Healthcare Concerns Directly to Lawmakers in Washington DC 5314 3Argonne 26apos 3Bs Advanced Photon Source Lit the Way to Chemistry Nobel 14392 1Argonne 26apos 3Bs Advanced Photon Source Lit the Way to Chemistry Nobel 14392 2Argonne 26apos 3Bs Advanced Photon Source Lit the Way to Chemistry Nobel 14392 3Statement from Senators Daschle and Dole 59109 1
...NAPOLIS, Feb. 26 America,s pharmaceutical researc... number of potential medicines to treat two of the...port by the Pharmaceutical Research and Manufactur...h pipeline, over 300 new medicines are in developm... report reflects the never-ending commitment of ou...
...ubset analysis of bortezomib-relapsed patient popu...extended time to progression , , NEW YORK, Feb. 2...) today announced updated clinical results from an...in combination with bortezomib (+/- dexamethasone)...loma. The data, which was presented earlier today ...
Other Medicine Technology:Report on 300 New Medicines in Development for Heart Disease and Stroke Released in Indianapolis 2Report on 300 New Medicines in Development for Heart Disease and Stroke Released in Indianapolis 3Report on 300 New Medicines in Development for Heart Disease and Stroke Released in Indianapolis 4Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data on KRX-0401 (Perifosine) in Combination with Bortezomib (+/- Dexamethasone) at the 12th International Multiple Myeloma Meeting 2Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data on KRX-0401 (Perifosine) in Combination with Bortezomib (+/- Dexamethasone) at the 12th International Multiple Myeloma Meeting 3Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data on KRX-0401 (Perifosine) in Combination with Bortezomib (+/- Dexamethasone) at the 12th International Multiple Myeloma Meeting 4
Myoglobin ELISA
...for the quantitative determination of prolactin in...s and treatment of disorders of the anterior pitui...titative Test is based on the principle of a solid...y system utilized sheep anti-prolactin for solid p...
Prolactin EIA kit
... kit for the quantitative determination of Human P...noassay (EIA) permits the routine quantitative det... and provides an accurate, sensitive, reproducible...y method makes it possible to measure low concentr...
Medicine Products: